0 CHECKOUT

Cameroon Pharmaceuticals and Healthcare Report Q2 2016

  • ID: 3616098
  • February 2016
  • Region: Cameroon
  • 49 pages
  • Business Monitor International
1 of 3

Economic expansion in Cameroon, driven mainly by ambitious investment projects in the infrastructure network, will have a positive effect on overall economic activity and private consumption over the next few years, which will benefit pharmaceutical and healthcare sector growth. In line with our view in the prior quarter, such economic trends will continue to be reflected in a modest, but rising interest by investors in pharmaceutical and healthcare sector opportunities in the country, which is illustrated by recent industrial and commercial investments by Tunisian pharmaceutical firm Teriak Laboratories in Douala, Cameroon. However, despite gradual efforts by Cameroonian authorities to improve the overall business environment, this will remain significantly challenging, while political risks are weighed to the downside due to succession uncertainty and regional instability, weighing on the country's full potential.

Headline Expenditure Projections

- Pharmaceuticals: XAF217.14bn (USD364mn) in 2015 to XAF244.62bn (USD399mn) in 2016; +12.7% in local currency terms and +9.6% in US dollar terms. Forecast revised upwards from last quarter.

Note: Product cover images may vary from those shown
2 of 3

Industry View
Table: Headline PharmaceuticalsHealthcare Forecasts (Cameroon 2014-2020)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cameroon 2012-2020)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020)

Industry Risk Reward Index

Middle East and Africa Risk/Reward IndexQ2 2016

Cameroon Risk/Reward Index

Rewards

Risks

Regulatory Review

Market Overview

Healthcare Sector

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Multinational Market Activity

Demographic Forecast
Table: Population Headline Indicators (Cameroon 1990-2025)
Table: Key Population Ratios (Cameroon 1990-2025)
Table: Urban/Rural PopulationLife Expectancy (Cameroon 1990-2025)
Table: Population By Age Group (Cameroon 1990-2025)
Table: Population By Age Group(Cameroon 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S